We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DKNG icon
526
PUT
DraftKings
DKNG
$9.72B
$4.13K ﹤0.01%
82,500
– –
2022 Q1
6 quarters
CSTA.WS
527
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
$3.91K ﹤0.01%
139,600
– –
2022 Q1
6 quarters
FAASW icon
528
DELISTED
DigiAsia Corp Warrant
FAASW
$3.84K ﹤0.01%
138,661
– –
2023 Q1
2 quarters
FICVW
529
DELISTED
Frontier Investment Corp Warrants
FICVW
$3.71K ﹤0.01%
32,524
– –
2021 Q3
8 quarters
SFRWW
530
DELISTED
Appreciate Holdings, Inc. Warrant
SFRWW
$2.88K ﹤0.01%
230,109
– –
2021 Q1
10 quarters
BLUA.WS icon
531
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$2.65K ﹤0.01%
49,521
– –
2022 Q1
6 quarters
MORF icon
532
CALL
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$2.63K ﹤0.01%
+15,000
New +$787K
2023 Q3
0 quarters
RDZNW icon
533
Roadzen Inc Warrants
RDZNW
$2.6K ﹤0.01%
68,781
– –
2022 Q2
5 quarters
CSLMW icon
534
DELISTED
CSLM Acquisition Corp. Warrant
CSLMW
$2.59K ﹤0.01%
68,781
– –
2023 Q1
2 quarters
MRT.WS icon
535
DELISTED
Marti Technologies, Inc. Warrants, each whole warrant exercisable for one class A ordinary share at an exercise price of $11.50
MRT.WS
$2.39K ﹤0.01%
+115,551
New +$6.75K
2023 Q3
0 quarters
CBAY icon
536
PUT
DELISTED
Cymabay Therapeutics
CBAY
$2.25K ﹤0.01%
+90,000
New +$1.19M
2023 Q3
0 quarters
OPTXW icon
537
Syntec Optics Holdings Warrant
OPTXW
$27.4M
$2.24K ﹤0.01%
47,932
– –
2022 Q1
6 quarters
AENTW icon
538
Alliance Entertainment Holding Corp Warrants
AENTW
$1.53M
$2.22K ﹤0.01%
116,781
– –
2023 Q2
1 quarter
ALORW
539
DELISTED
ALSP Orchid Acquisition Corp I Warrant
ALORW
$2.15K ﹤0.01%
62,909
– –
2022 Q1
6 quarters
BOAC.WS
540
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$1.97K ﹤0.01%
226,519
– –
2021 Q1
10 quarters
CRNX icon
541
PUT
DELISTED
Crinetics Pharmaceuticals
CRNX
$875 ﹤0.01%
+35,000
New +$721K
2023 Q3
0 quarters
SILK icon
542
CALL
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$750 ﹤0.01%
+30,000
New +$624K
2023 Q3
0 quarters
WINVW icon
543
DELISTED
WinVest Acquisition Corp. Warrant
WINVW
$276 ﹤0.01%
18,392
– –
2023 Q1
2 quarters
SDSTW icon
544
Stardust Power Inc Warrant
SDSTW
$4.92M
$120 ﹤0.01%
37,521
– –
2021 Q1
10 quarters
AAOI icon
545
CALL
Applied Optoelectronics
AAOI
$9.31B
– –
-100,000
Closed -$165K –
AAT icon
546
American Assets Trust
AAT
$1.32B
– –
-93,281
Closed -$1.79M –
ACI icon
547
Albertsons Companies
ACI
$5.92B
– –
-4,300,000
Closed -$93.8M –
ADI icon
548
Analog Devices
ADI
$197B
– –
-15,000
Closed -$2.92M –
AGIO icon
549
CALL
Agios Pharmaceuticals
AGIO
$1.9B
– –
-50,000
Closed -$23.8K –
AMC icon
550
PUT
AMC Entertainment Holdings
AMC
$2.66B
– –
-35,000
Closed -$811K –

Similar funds

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.